drugset / Trial / NCT03464864
Pharmacokinetics, Safety and Tolerability of Treprostinil Inhalation Powder in Healthy Normal Volunteers
Non-randomizedSingle-groupOpen-labelOther
Summary
A Dose-Rising Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of Treprostinil Inhalation Powder in Healthy Normal Volunteers
Timeline
- Start
- 2018-03-09
- Primary completion
- 2018-06-05
- Completion
- 2018-06-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Treprostinil | Other / unclassified | 30 ug | Inhaled |
| Subject | Treprostinil | Other / unclassified | 60 ug | Inhaled |
| Subject | Treprostinil | Other / unclassified | 90 ug | Inhaled |
| Subject | Treprostinil | Other / unclassified | 120 ug | Inhaled |
| Subject | Treprostinil | Other / unclassified | 150 ug | Inhaled |
| Subject | Treprostinil | Other / unclassified | 180 ug | Inhaled |
| Subject | Treprostinil | Other / unclassified | 240 ug | Inhaled |
| Subject | Treprostinil | Other / unclassified | 300 ug | Inhaled |